<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>53</viewCount><searchCount>0</searchCount></scores><additional><submitter>Morita M</submitter><funding>NIGMS NIH HHS</funding><pagination>6044-6048</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6242345</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>140(19)</volume><pubmed_abstract>Prenylation is a widespread modification that improves the biological activities of secondary metabolites. This reaction also represents a key modification step in biosyntheses of cyanobactins, a family of ribosomally synthesized and post-translationally modified peptides (RiPPs) produced by cyanobacteria. In cyanobactins, amino acids are commonly isoprenylated by ABBA prenyltransferases that use C5 donors. Notably, mass spectral analysis of piricyclamides from a fresh-water cyanobacterium suggested that they may instead have a C10 geranyl group. Here we characterize a novel geranyltransferase involved in piricyclamide biosynthesis. Using the purified enzyme, we show that the enzyme PirF catalyzes Tyr O-geranylation, which is an unprecedented post-translational modification. In addition, the combination of enzymology and analytical chemistry revealed the structure of the final natural product, piricyclamide 7005E1, and the regioselectivity of PirF, which has potential as a synthetic biological tool providing drug-like properties to diverse small molecules.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Post-Translational Tyrosine Geranylation in Cyanobactin Biosynthesis.</pubmed_title><pmcid>PMC6242345</pmcid><funding_grant_id>R35 GM122521</funding_grant_id><funding_grant_id>R01 GM079038</funding_grant_id><funding_grant_id>R01 GM102602</funding_grant_id><pubmed_authors>Jokela JK</pubmed_authors><pubmed_authors>Sardar D</pubmed_authors><pubmed_authors>Sivonen K</pubmed_authors><pubmed_authors>Nair SK</pubmed_authors><pubmed_authors>Schmidt EW</pubmed_authors><pubmed_authors>Morita M</pubmed_authors><pubmed_authors>Hao Y</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><view_count>53</view_count></additional><is_claimable>false</is_claimable><name>Post-Translational Tyrosine Geranylation in Cyanobactin Biosynthesis.</name><description>Prenylation is a widespread modification that improves the biological activities of secondary metabolites. This reaction also represents a key modification step in biosyntheses of cyanobactins, a family of ribosomally synthesized and post-translationally modified peptides (RiPPs) produced by cyanobacteria. In cyanobactins, amino acids are commonly isoprenylated by ABBA prenyltransferases that use C5 donors. Notably, mass spectral analysis of piricyclamides from a fresh-water cyanobacterium suggested that they may instead have a C10 geranyl group. Here we characterize a novel geranyltransferase involved in piricyclamide biosynthesis. Using the purified enzyme, we show that the enzyme PirF catalyzes Tyr O-geranylation, which is an unprecedented post-translational modification. In addition, the combination of enzymology and analytical chemistry revealed the structure of the final natural product, piricyclamide 7005E1, and the regioselectivity of PirF, which has potential as a synthetic biological tool providing drug-like properties to diverse small molecules.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2020-10-31T08:16:46Z</modification><creation>2019-03-27T00:08:02Z</creation></dates><accession>S-EPMC6242345</accession><cross_references><pubmed>29701961</pubmed><doi>10.1021/jacs.8b03137</doi></cross_references></HashMap>